08:25 AM EDT, 06/13/2024 (MT Newswires) -- BioRestorative Therapies ( BRTX ) said Thursday it is in "substantive" licensing talks for its off-the-shelf metabolic intellectual property.

The company said its potential license partner for its ThermoStem metabolic disease program is "a leading commercial stage regenerative medicine company."

BioRestorative Therapies ( BRTX ) said there's no assurance that a license agreement will be struck.

The company's shares rose 36% in premarket activity.

Price: 1.8700, Change: +0.53, Percent Change: +40.07